Morphotek

Major Japanese pharma firm Eisai Co. Ltd. has set up a new corporate venture capital fund that intends to invest up to JPY3bn ($27.3m) annually over the next five years, the over-arching aim being t

IN VITRO DIAGNOSTICS Mergers & Acquisitions Oxford Immunotec Global PLC Immunetics Inc. Oxford Immunotec Global PLC is paying $6mm in cash to acquire Immunetics Inc. (immunoassays for infectio

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between Oct. 4-14. Deal Watc

IN VITRO DIAGNOSTICS Alliances Dentamed Ltd. Diamedica Ltd. SIRAM Ltd. Vigilant Biosciences Inc. Vigilant Biosciences Inc. signed three new multi-year distribution agreements for marketing of its